In this project, IBioIC funded a team of scientists at Edinburgh University to work with ILC Therapeutics to develop a platform that could produce hybrid proteins, based on the Type 1 Interferons, with enhanced cancer fighting capabilities.
Read MoreAskBio accelerate their product design thanks to IBioIC project funding.
Read More